{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Financial Desk", "lead_paragraph": "THE big drug stocks got off to a dreary start in 1992, losing more than 11 percent of their value in 10 weeks. Some equity fund managers were quick to cut back their holdings, having profited from strong price rises in December. Hoping for an economic upturn, many funds moved away from supposedly recession-proof stocks like drugs, food and beverages to cyclicals like autos, banks, chemicals and paper.", "headline": {"main": "Market Place; Drug Stocks Slip Into the Doldrums"}, "abstract": null, "print_page": "6", "word_count": 724, "_id": "4fd1b5048eb7c8105d6da307", "snippet": "THE big drug stocks got off to a dreary start in 1992, losing more than 11 percent of their value in 10 weeks. Some equity fund managers were quick to cut back their holdings, having profited from strong price rises in December.   Hoping for an...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1992/03/20/business/market-place-drug-stocks-slip-into-the-doldrums.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "MARKET PLACE (TIMES COLUMN)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "INVESTMENT STRATEGIES"}, {"name": "subject", "value": "STOCKS AND BONDS"}, {"name": "subject", "value": "STOCK PRICES AND TRADING VOLUME"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "Freudenheim"}], "original": "By Milt Freudenheim"}, "document_type": "article", "pub_date": "1992-03-20T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Leading members of Congress say they are swamped with conflicting messages from a growing number of lobbyists and lawyers representing all facets of the health-care industry. Moreover, no one expects those trends to be reversed in the next decade as the Government assumes a bigger role in financing health care.", "headline": {"main": "Conflicting Aims in Booming Health Care Lobby Help Stall Congress"}, "abstract": null, "print_page": "17", "word_count": 1308, "_id": "4fd19f208eb7c8105d6b2a4f", "snippet": "Leading members of Congress say they are swamped with conflicting messages from a growing number of lobbyists and lawyers representing all facets of the health-care industry.   Moreover, no one expects those trends to be reversed in the next decade...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1992/03/18/us/conflicting-aims-in-booming-health-care-lobby-help-stall-congress.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "AMERICAN MEDICAL ASSN"}, {"name": "organizations", "value": "COMMON CAUSE"}, {"name": "subject", "value": "REFORM AND REORGANIZATION"}, {"name": "subject", "value": "LABOR UNIONS"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "HOSPITALS"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "NURSING HOMES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "1992-03-18T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 2, "offset": 0, "time": 54}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}